Abstract:BACKGROUND:Neuropathic pain is still a challenge for clinical treatment as a result of the comprehensive pathogenesis. Although emerging evidence demonstrates the pivotal role of glial cells in regulating neuropathic pain, the role of Schwann cells and their underlying mechanisms still need to be uncovered. Pannexin 1 (Panx 1), an important membrane channel for the release of ATP and inflammatory cytokines, as well as its activation in central glial cells, contributes to pain development. Here, we hypothesized that Schwann cell Panx 1 participates in the regulation of neuroinflammation and contributes to neuropathic pain.METHODS:A mouse model of chronic constriction injury (CCI) in CD1 adult mice or P0-Cre transgenic mice, and in vitro cultured Schwann cells were used. Intrasciatic injection with Panx 1 blockers or the desired virus was used to knock down the expression of Panx 1. Mechanical and thermal sensitivity was assessed using Von Frey and a hot plate assay. The expression of Panx 1 was measured using qPCR, western blotting, and immunofluorescence. The production of cytokines was monitored through qPCR and enzyme-linked immunosorbent assay (ELISA). Panx1 channel activity was detected by ethidium bromide (EB) uptake.RESULTS:CCI induced persistent neuroinflammatory responses and upregulation of Panx 1 in Schwann cells. Intrasciatic injection of Panx 1 blockers, carbenoxolone (CBX), probenecid, and Panx 1 mimetic peptide (10Panx) effectively reduced mechanical and heat hyperalgesia. Probenecid treatment of CCI-induced mice significantly reduced Panx 1 expression in Schwann cells, but not in dorsal root ganglion (DRG). In addition, Panx 1 knockdown in Schwann cells with Panx 1 shRNA-AAV in P0-Cre mice significantly reduced CCI-induced neuropathic pain. To determine whether Schwann cell Panx 1 participates in the regulation of neuroinflammation and contributes to neuropathic pain, we evaluated its effect in LPS-treated Schwann cells. We found that inhibition of Panx 1 via CBX and Panx 1-siRNA effectively attenuated the production of selective cytokines, as well as its mechanism of action being dependent on both Panx 1 channel activity and its expression.CONCLUSION:In this study, we found that CCI-related neuroinflammation correlates with Panx 1 activation in Schwann cells, indicating that inhibition of Panx 1 channels in Schwann cells reduces neuropathic pain through the suppression of neuroinflammatory responses.

The research progress in the functions of pannexin

[The Properties and Research Methods of Pannexins].

Pannexin1 Channel Inhibitor (10panx) Protects Against Transient Focal Cerebral Ischemic Injury by Inhibiting RIP3 Expression and Inflammatory Response in Rats.

Pannexin 1, a Large-Pore Membrane Channel, Contributes to Hypotonicity-Induced ATP Release in Schwann Cells.

Recent advances in the structure and activation mechanisms of metabolite-releasing Pannexin 1 channels

[Gap Junction and Function of Brain].

Mechanisms of Pannexin 1 (PANX1) Channel Mechanosensitivity and Its Pathological Roles

Expression and function of pannexins in the inner ear and hearing

Pannexins in the musculoskeletal system: new targets for development and disease progression

Targeting Pannexin-1 Channels: Addressing the 'Gap' in Chronic Pain

Cryo-EM structures of human pannexin 1 channel

Pannexin1 channels-a potential therapeutic target in inflammation

Cryo-EM structures of pannexin 1 and 3 reveal differences among pannexin isoforms

Cryo-EM Structure of Human Heptameric Pannexin 1 Channel

Divergence between Hemichannel and Gap Junction Permeabilities of Connexin 30 and 26

Connexin Hemichannels in Astrocytes: Role in CNS Disorders

Inhibition of Schwann Cell Pannexin 1 Attenuates Neuropathic Pain Through the Suppression of Inflammatory Responses

Connexin hemichannels and pannexin channels in toxicity: Recent advances and mechanistic insights

Research advances in regulation of gap junctional intercellular communication

Expression of Pannexin3 in human odontoblast-like cells and its hemichannel function in mediating ATP release

Effect of Pannexin-1 on the Release of Glutamate and Cytokines in Astrocytes